Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03761914
Title Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sellas Life Sciences Group
Indications

colorectal cancer

ovarian cancer

fallopian tube cancer

Advanced Solid Tumor

peritoneum cancer

acute myeloid leukemia

lung small cell carcinoma

triple-receptor negative breast cancer

Therapies

Galinpepimut-S

Galinpepimut-S + Pembrolizumab

Pembrolizumab

Sargramostim

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.